CHA Bio's U.S. subsidiary to team up with Sartorius for viral vector process technology
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
Under the agreement, Matica will use Sartorius’ single-use platform that utilizes disposable bioreactors designed to reduce the risk of cross-contamination between batches while providing space, time and cost flexibility. The two will cooperate to develop real-time process analytical technology (PAT) and automation software needed for large-scale vector production with superiority in turnaround time and quality.
Satorius, the largest player in the single-use platform market, is a global provider of advanced equipment and technical services for biopharmaceutical process, R&D, and quality assurance, among others. Matica specializes in the clinical and commercial production of viral vectors for cell and gene therapies.
[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- Hyundai Glovis, Air Products tie up on liquid hydrogen supply network - Pulse by Maeil Business News Korea
- Korean defense firms pitch aerospace, defense systems at ADEX 2021 - Pulse by Maeil Business News Korea
- Toss reforms wage and leave system to improve working environment - Pulse by Maeil Business News Korea
- Foreigners cherry-pick EV battery stocks while net-selling Korean stocks in Oct - Pulse by Maeil Business News Korea
- Kakao Pay’s delayed IPO to be priced at lowered band of $51-77 - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- FI “1조 돌려달라”…정용진 ‘머니게임’ 毒 됐나
- 대만 치어리더 한국스포츠 첫 진출…K리그 수원FC - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이